A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma
Cohen, Jonathon B., Switchenko, Jeffrey M., Koff, Jean L., Sinha, Rajni, Kaufman, Jonathan L., Khoury, H. Jean, Bumpers, Nassoma, Colbert, Amanda, Hutchison-Rzepka, Amanda, Nastoupil, Loretta J., HeffVolume:
171
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13637
Date:
November, 2015
File:
PDF, 105 KB
english, 2015